Loading…

Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells

Several attempts to attack tumours in experimental systems have been made using conjugates of chemotherapeutic agents or potent toxins with antibodies (immunotoxins) 1–8 . In vitro studies have been highly successful, showing target specificity of a high order in some cases 6–8 . However, so far, su...

Full description

Saved in:
Bibliographic Details
Published in:Nature (London) 1981-03, Vol.290 (5802), p.145-146
Main Authors: Blythman, Hildur E, Casellas, Pierre, Gros, Olivier, Gros, Pierre, Jansen, Franz K, Paolucci, Francis, Pau, Bernard, Vidal, Hubert
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c335t-70700c1b54f61ed59cf582b0dca1e1cdd058c1ef36b9974257bdf72a88031e063
cites cdi_FETCH-LOGICAL-c335t-70700c1b54f61ed59cf582b0dca1e1cdd058c1ef36b9974257bdf72a88031e063
container_end_page 146
container_issue 5802
container_start_page 145
container_title Nature (London)
container_volume 290
creator Blythman, Hildur E
Casellas, Pierre
Gros, Olivier
Gros, Pierre
Jansen, Franz K
Paolucci, Francis
Pau, Bernard
Vidal, Hubert
description Several attempts to attack tumours in experimental systems have been made using conjugates of chemotherapeutic agents or potent toxins with antibodies (immunotoxins) 1–8 . In vitro studies have been highly successful, showing target specificity of a high order in some cases 6–8 . However, so far, such conjugates have been inadequate in vivo , probably for two main reasons. First, conventional heteroclonal antibodies are perhaps inappropriate, because purification by biochemical methods leaves a large amount of non-antibody γ-globulins. The use of monoclonal antibodies may overcome this problem. Second, when whole toxins have been conjugated to antibodies there has been a strong residual nonspecific cytotoxicity due to the binding capacity of a subunit, the B-piece of the toxin. (Diphtheria toxin or ricin consist of two polypeptide subunits. The A-piece is responsible for inhibition of protein synthesis on ribosomes, and the B-piece binds to galactose residues on the cell membrane and facilitates the transmembrane passage of the A-piece.) In the present work the problem of nonspecific binding by the B-piece has been circumvented by using the A-piece only as the toxin component of immunotoxins; these immunotoxins are active both in vitro and in vivo .
doi_str_mv 10.1038/290145a0
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1038_290145a0</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>7207595</sourcerecordid><originalsourceid>FETCH-LOGICAL-c335t-70700c1b54f61ed59cf582b0dca1e1cdd058c1ef36b9974257bdf72a88031e063</originalsourceid><addsrcrecordid>eNptkMtOwzAQRS0EKqUg8QMgL2ERGCdx7LBDFY9KldjAOvITXBy7ihOJ_j2Blq5YjUb3zJXmIHRO4IZAwW_zGkhJBRygKSlZlZUVZ4doCpDzDHhRHaOTlFYAQAkrJ2jCcmC0plO0WrTtEGIfv1xId_hjIzuncRu9UYM3CUc7LiEqH4PwWITeyajdGIigscC_dzgNcgiux2ltlLNOCe83-NN5j_uhjUOHlfE-naIjK3wyZ7s5Q2-PD6_z52z58rSY3y8zVRS0zxgwAEUkLW1FjKa1spTnErQSxBClNVCuiLFFJeualTllUluWC86hIAaqYoautr2qiyl1xjbrzrWi2zQEmh9bzZ-tEb3YoutBtkbvwZ2eMb_e5mlMwrvpmtX4zmgi_dd1uWWD6IfO7Lv2wDcPw33b</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells</title><source>Nature</source><creator>Blythman, Hildur E ; Casellas, Pierre ; Gros, Olivier ; Gros, Pierre ; Jansen, Franz K ; Paolucci, Francis ; Pau, Bernard ; Vidal, Hubert</creator><creatorcontrib>Blythman, Hildur E ; Casellas, Pierre ; Gros, Olivier ; Gros, Pierre ; Jansen, Franz K ; Paolucci, Francis ; Pau, Bernard ; Vidal, Hubert</creatorcontrib><description>Several attempts to attack tumours in experimental systems have been made using conjugates of chemotherapeutic agents or potent toxins with antibodies (immunotoxins) 1–8 . In vitro studies have been highly successful, showing target specificity of a high order in some cases 6–8 . However, so far, such conjugates have been inadequate in vivo , probably for two main reasons. First, conventional heteroclonal antibodies are perhaps inappropriate, because purification by biochemical methods leaves a large amount of non-antibody γ-globulins. The use of monoclonal antibodies may overcome this problem. Second, when whole toxins have been conjugated to antibodies there has been a strong residual nonspecific cytotoxicity due to the binding capacity of a subunit, the B-piece of the toxin. (Diphtheria toxin or ricin consist of two polypeptide subunits. The A-piece is responsible for inhibition of protein synthesis on ribosomes, and the B-piece binds to galactose residues on the cell membrane and facilitates the transmembrane passage of the A-piece.) In the present work the problem of nonspecific binding by the B-piece has been circumvented by using the A-piece only as the toxin component of immunotoxins; these immunotoxins are active both in vitro and in vivo .</description><identifier>ISSN: 0028-0836</identifier><identifier>EISSN: 1476-4687</identifier><identifier>DOI: 10.1038/290145a0</identifier><identifier>PMID: 7207595</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Animals ; Antibodies, Neoplasm - administration &amp; dosage ; Antibody Specificity ; Antineoplastic Agents - administration &amp; dosage ; Cells, Cultured ; Clone Cells ; Humanities and Social Sciences ; Immunoglobulin M - administration &amp; dosage ; letter ; Leukemia, Experimental - drug therapy ; Mice ; Mice, Inbred BALB C ; multidisciplinary ; Neoplasm Transplantation ; Ricin - administration &amp; dosage ; Science ; Science (multidisciplinary) ; Toxins, Biological - metabolism</subject><ispartof>Nature (London), 1981-03, Vol.290 (5802), p.145-146</ispartof><rights>Springer Nature Limited 1981</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c335t-70700c1b54f61ed59cf582b0dca1e1cdd058c1ef36b9974257bdf72a88031e063</citedby><cites>FETCH-LOGICAL-c335t-70700c1b54f61ed59cf582b0dca1e1cdd058c1ef36b9974257bdf72a88031e063</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,2727,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7207595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Blythman, Hildur E</creatorcontrib><creatorcontrib>Casellas, Pierre</creatorcontrib><creatorcontrib>Gros, Olivier</creatorcontrib><creatorcontrib>Gros, Pierre</creatorcontrib><creatorcontrib>Jansen, Franz K</creatorcontrib><creatorcontrib>Paolucci, Francis</creatorcontrib><creatorcontrib>Pau, Bernard</creatorcontrib><creatorcontrib>Vidal, Hubert</creatorcontrib><title>Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells</title><title>Nature (London)</title><addtitle>Nature</addtitle><addtitle>Nature</addtitle><description>Several attempts to attack tumours in experimental systems have been made using conjugates of chemotherapeutic agents or potent toxins with antibodies (immunotoxins) 1–8 . In vitro studies have been highly successful, showing target specificity of a high order in some cases 6–8 . However, so far, such conjugates have been inadequate in vivo , probably for two main reasons. First, conventional heteroclonal antibodies are perhaps inappropriate, because purification by biochemical methods leaves a large amount of non-antibody γ-globulins. The use of monoclonal antibodies may overcome this problem. Second, when whole toxins have been conjugated to antibodies there has been a strong residual nonspecific cytotoxicity due to the binding capacity of a subunit, the B-piece of the toxin. (Diphtheria toxin or ricin consist of two polypeptide subunits. The A-piece is responsible for inhibition of protein synthesis on ribosomes, and the B-piece binds to galactose residues on the cell membrane and facilitates the transmembrane passage of the A-piece.) In the present work the problem of nonspecific binding by the B-piece has been circumvented by using the A-piece only as the toxin component of immunotoxins; these immunotoxins are active both in vitro and in vivo .</description><subject>Animals</subject><subject>Antibodies, Neoplasm - administration &amp; dosage</subject><subject>Antibody Specificity</subject><subject>Antineoplastic Agents - administration &amp; dosage</subject><subject>Cells, Cultured</subject><subject>Clone Cells</subject><subject>Humanities and Social Sciences</subject><subject>Immunoglobulin M - administration &amp; dosage</subject><subject>letter</subject><subject>Leukemia, Experimental - drug therapy</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>multidisciplinary</subject><subject>Neoplasm Transplantation</subject><subject>Ricin - administration &amp; dosage</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Toxins, Biological - metabolism</subject><issn>0028-0836</issn><issn>1476-4687</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1981</creationdate><recordtype>article</recordtype><recordid>eNptkMtOwzAQRS0EKqUg8QMgL2ERGCdx7LBDFY9KldjAOvITXBy7ihOJ_j2Blq5YjUb3zJXmIHRO4IZAwW_zGkhJBRygKSlZlZUVZ4doCpDzDHhRHaOTlFYAQAkrJ2jCcmC0plO0WrTtEGIfv1xId_hjIzuncRu9UYM3CUc7LiEqH4PwWITeyajdGIigscC_dzgNcgiux2ltlLNOCe83-NN5j_uhjUOHlfE-naIjK3wyZ7s5Q2-PD6_z52z58rSY3y8zVRS0zxgwAEUkLW1FjKa1spTnErQSxBClNVCuiLFFJeualTllUluWC86hIAaqYoautr2qiyl1xjbrzrWi2zQEmh9bzZ-tEb3YoutBtkbvwZ2eMb_e5mlMwrvpmtX4zmgi_dd1uWWD6IfO7Lv2wDcPw33b</recordid><startdate>19810312</startdate><enddate>19810312</enddate><creator>Blythman, Hildur E</creator><creator>Casellas, Pierre</creator><creator>Gros, Olivier</creator><creator>Gros, Pierre</creator><creator>Jansen, Franz K</creator><creator>Paolucci, Francis</creator><creator>Pau, Bernard</creator><creator>Vidal, Hubert</creator><general>Nature Publishing Group UK</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19810312</creationdate><title>Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells</title><author>Blythman, Hildur E ; Casellas, Pierre ; Gros, Olivier ; Gros, Pierre ; Jansen, Franz K ; Paolucci, Francis ; Pau, Bernard ; Vidal, Hubert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c335t-70700c1b54f61ed59cf582b0dca1e1cdd058c1ef36b9974257bdf72a88031e063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1981</creationdate><topic>Animals</topic><topic>Antibodies, Neoplasm - administration &amp; dosage</topic><topic>Antibody Specificity</topic><topic>Antineoplastic Agents - administration &amp; dosage</topic><topic>Cells, Cultured</topic><topic>Clone Cells</topic><topic>Humanities and Social Sciences</topic><topic>Immunoglobulin M - administration &amp; dosage</topic><topic>letter</topic><topic>Leukemia, Experimental - drug therapy</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>multidisciplinary</topic><topic>Neoplasm Transplantation</topic><topic>Ricin - administration &amp; dosage</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Toxins, Biological - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Blythman, Hildur E</creatorcontrib><creatorcontrib>Casellas, Pierre</creatorcontrib><creatorcontrib>Gros, Olivier</creatorcontrib><creatorcontrib>Gros, Pierre</creatorcontrib><creatorcontrib>Jansen, Franz K</creatorcontrib><creatorcontrib>Paolucci, Francis</creatorcontrib><creatorcontrib>Pau, Bernard</creatorcontrib><creatorcontrib>Vidal, Hubert</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Nature (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Blythman, Hildur E</au><au>Casellas, Pierre</au><au>Gros, Olivier</au><au>Gros, Pierre</au><au>Jansen, Franz K</au><au>Paolucci, Francis</au><au>Pau, Bernard</au><au>Vidal, Hubert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells</atitle><jtitle>Nature (London)</jtitle><stitle>Nature</stitle><addtitle>Nature</addtitle><date>1981-03-12</date><risdate>1981</risdate><volume>290</volume><issue>5802</issue><spage>145</spage><epage>146</epage><pages>145-146</pages><issn>0028-0836</issn><eissn>1476-4687</eissn><abstract>Several attempts to attack tumours in experimental systems have been made using conjugates of chemotherapeutic agents or potent toxins with antibodies (immunotoxins) 1–8 . In vitro studies have been highly successful, showing target specificity of a high order in some cases 6–8 . However, so far, such conjugates have been inadequate in vivo , probably for two main reasons. First, conventional heteroclonal antibodies are perhaps inappropriate, because purification by biochemical methods leaves a large amount of non-antibody γ-globulins. The use of monoclonal antibodies may overcome this problem. Second, when whole toxins have been conjugated to antibodies there has been a strong residual nonspecific cytotoxicity due to the binding capacity of a subunit, the B-piece of the toxin. (Diphtheria toxin or ricin consist of two polypeptide subunits. The A-piece is responsible for inhibition of protein synthesis on ribosomes, and the B-piece binds to galactose residues on the cell membrane and facilitates the transmembrane passage of the A-piece.) In the present work the problem of nonspecific binding by the B-piece has been circumvented by using the A-piece only as the toxin component of immunotoxins; these immunotoxins are active both in vitro and in vivo .</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>7207595</pmid><doi>10.1038/290145a0</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-0836
ispartof Nature (London), 1981-03, Vol.290 (5802), p.145-146
issn 0028-0836
1476-4687
language eng
recordid cdi_crossref_primary_10_1038_290145a0
source Nature
subjects Animals
Antibodies, Neoplasm - administration & dosage
Antibody Specificity
Antineoplastic Agents - administration & dosage
Cells, Cultured
Clone Cells
Humanities and Social Sciences
Immunoglobulin M - administration & dosage
letter
Leukemia, Experimental - drug therapy
Mice
Mice, Inbred BALB C
multidisciplinary
Neoplasm Transplantation
Ricin - administration & dosage
Science
Science (multidisciplinary)
Toxins, Biological - metabolism
title Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T21%3A02%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunotoxins:%20hybrid%20molecules%20of%20monoclonal%20antibodies%20and%20a%20toxin%20subunit%20specifically%20kill%20tumour%20cells&rft.jtitle=Nature%20(London)&rft.au=Blythman,%20Hildur%20E&rft.date=1981-03-12&rft.volume=290&rft.issue=5802&rft.spage=145&rft.epage=146&rft.pages=145-146&rft.issn=0028-0836&rft.eissn=1476-4687&rft_id=info:doi/10.1038/290145a0&rft_dat=%3Cpubmed_cross%3E7207595%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c335t-70700c1b54f61ed59cf582b0dca1e1cdd058c1ef36b9974257bdf72a88031e063%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/7207595&rfr_iscdi=true